Authors' objectives: The health technologies assessed include rtCGM systems and FGM systems as personal, stand­alone medical devices for patients with diabetes mellitus type 1 and type 2 (T1DM and T2DM), including adults, children, and patients with gestational DM treated with insulin, either through insulin pump therapy (CSII) or multiple daily insulin injections (MDII). Professional (retrospective) devices are not included in this assessment. The objective of this rapid assessment was to evaluate the relative effectiveness and safety of real-time continuous glucose monitoring (rtCGM) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin. We do not provide any recommendations; this is left to national/regional and local HTA processes, appraisal processes, and decision-making.

Project Status: Completed

URL for project: https://eunethta.eu/the-joint-assessment-on-continuous-glucose-monitoring-cgm-real-time-and-flash-glucose-monitoring-fgm-as-personal-standalone-systems-in-patients-with-diabetes-mellitus-treated-with-insuli/

Year Published: 2018

URL for published report: https://eunethta.eu/the-joint-assessment-on-continuous-glucose-monitoring-cgm-real-time-and-flash-glucose-monitoring-fgm-as-personal-standalone-systems-in-patients-with-diabetes-mellitus-treated-with-insuli/

Requestor: HTA agencies

English language abstract: An English language summary is available

Publication Type: Rapid Review

Organisation Name: European Network for Health Technology Assessment

Contact Email: eunethta@zinl.nl

Copyright: CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.